Matches in Nanopublications for { ?s ?p "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP107633.RAhFlAVWfMf97t1TJgLlpa8-cQYPpdTWnG1t8JOOT2QWg130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107633.RAhFlAVWfMf97t1TJgLlpa8-cQYPpdTWnG1t8JOOT2QWg130_provenance.
- NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107893.RAs7mt_oKF9s6-QlOMjGamRrC3H0l0vU0X8Wq7jd_PhNE130_provenance.
- NP109689.RAzEm9zFfM-K35uK61QU51fQQPPsHWVGu9kJPJBkk-YKM130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109689.RAzEm9zFfM-K35uK61QU51fQQPPsHWVGu9kJPJBkk-YKM130_provenance.
- NP211699.RAY1S7cBHf6zDqaIsKVhiMMwX1xpvpMSCGLlzoZEb2tOg130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211699.RAY1S7cBHf6zDqaIsKVhiMMwX1xpvpMSCGLlzoZEb2tOg130_provenance.
- NP170847.RA3uY7AuenAxEJc6LSMbxyocWmWMUKtOb1aXDWSed3ECo130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP170847.RA3uY7AuenAxEJc6LSMbxyocWmWMUKtOb1aXDWSed3ECo130_provenance.
- NP171107.RAzr5uKVd5CSEYDbAm2RcyXdq-rh8TFrUMpKDTvEyfgDQ130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171107.RAzr5uKVd5CSEYDbAm2RcyXdq-rh8TFrUMpKDTvEyfgDQ130_provenance.
- NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP172902.RAwM9g76RwZs-3dxyptLbVT5TENQUxOqp0KI2b_BHVRLI130_provenance.
- NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211700.RAJcHFhfR5byRgRt1zAWH7LYDp2e4QyQpdk65aRCfUDtU130_provenance.
- NP211698.RAwpnijUCxkbQQYBSwD2E0DNmg-8eGnBmhb5eL-5njTj4130_assertion description "[in breast cancer patients, Akt activation is associated with tumour proliferation and poor prognosis, particularly in the subset of patients with ErbB2-overexpressing tumours ]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211698.RAwpnijUCxkbQQYBSwD2E0DNmg-8eGnBmhb5eL-5njTj4130_provenance.